Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Brain Behav Immun. 2011 Jun 13;25(7):1475–1481. doi: 10.1016/j.bbi.2011.06.003

Table 2.

Frequency of HSV-2 genital lesions by treatment arm

All sessions Placebo Arm Acyclovir Arm
Number of days with genital lesions/all days (%) 259 / 2694 (10) 197 / 1360 (14) 62 / 1334 (5)**
Number of genital lesion episodes, N (%) 35 (100) 26 (74) 9 (26)*
Duration of genital lesion episodes (days), median (range) 6 (1–19) 7 (2–19) 4 (1–17)
*

p < 0.05

**

p < 0.001